Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Ms. Cristin HubbardExec. VP & Chief Commercial Officer | -2,32k | 116,36k | Sale to Issuer | 50,20 | 7,38k | -23,89% |
| 2026-05-07 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -3,28k | 176,68k | Vente | 53,85 | 51,82k | -5,95% |
| 2026-03-18 | Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary | -1,27k | 71,35k | Sale to Issuer | 56,05 | 78,56k | -1,59% |
| 2026-03-17 | Dr. C. Greg GuyerExec. VP & CTO | -1,69k | 94,89k | Sale to Issuer | 56,05 | 74,16k | -2,23% |
| 2026-03-17 | Mr. Brian R. MuellerCFO & Exec. VP of Finance | -2,12k | 118,66k | Sale to Issuer | 56,05 | 123,31k | -1,69% |
| 2026-03-17 | Mr. Alexander HardyPresident, CEO & Director | -4,25k | 238,32k | Sale to Issuer | 56,05 | 214,64k | -1,94% |
| 2026-03-17 | Ms. Cristin HubbardExec. VP & Chief Commercial Officer | -1,25k | 69,78k | Sale to Issuer | 56,05 | 7,58k | -14,11% |
| 2026-03-17 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -1,63k | 91,31k | Sale to Issuer | 56,05 | 55,10k | -2,87% |
| 2026-03-13 | Dr. C. Greg GuyerExec. VP & CTO | -9,11k | 532,97k | Sale to Issuer | 58,51 | 50,07k | -15,39% |
| 2026-03-16 | Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary | -7,18k | 419,93k | Sale to Issuer | 58,51 | 79,83k | -8,25% |
| 2026-03-13 | Mr. Brian R. MuellerCFO & Exec. VP of Finance | -9,95k | 581,88k | Sale to Issuer | 58,51 | 125,43k | -7,35% |
| 2026-03-16 | Mr. Alexander HardyPresident, CEO & Director | -2,94k | 172,08k | Sale to Issuer | 58,51 | 77,49k | -3,66% |
| 2026-03-11 | Dr. C. Greg GuyerExec. VP & CTO | -16,49k | 996,74k | Vente | 60,46 | 44,58k | -27,00% |
| 2026-02-26 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -6,33k | 381,94k | Vente | 60,38 | 37,58k | -14,41% |
| 2026-02-26 | Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary | -26,06k | 1,60M | Vente | 61,36 | 72,45k | -26,45% |
| 2025-12-30 | Mr. Richard A. MeierIndependent Chairman of the Board | -500,00 | 0,00 | Other Disposition | - | 120,28k | -0,41% |
| 2025-12-01 | Mr. Alexander HardyPresident, CEO & Director | -16,57k | 911,85k | Sale to Issuer | 55,03 | 40,65k | -28,96% |
| 2025-09-30 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -3,30k | 178,94k | Sale to Issuer | 54,16 | 43,51k | -7,06% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
